Kindred Capital
Venture capital firm based in London, UK
Latest Kindred Capital investments
Kindred Capital has invested in these startups.
Latent Labs
Latent Labs secures $50 million to make biology programmable, harnessing AI to unlock new possibilities in biotech. Exciting times ahead. Read more
Shift Bioscience
Shift Bioscience lands $16 million in seed funding to unleash AI-driven innovation in the fight against age-related diseases, promising a revolutionary leap in rejuvenation therapies. Read more
Puraffinity
Puraffinity secures £6.73 million to supercharge its groundbreaking PFAS removal technology, paving the way for cleaner water and a healthier planet. Read more
Fractile
Fractile secures $15M in Seed funding for groundbreaking AI chip, poised to revolutionize the industry with cutting-edge technology. Read more
LabGenius
LabGenius secures impressive £35M in Series B funding led by M Ventures, Merck's corporate venture capital arm, to advance their groundbreaking machine learning-driven drug discovery platform and pipeline of multispecific antibodies for solid tumors. Read more
Infinitopes
Infinitopes Precision Immunomics secures £12.8M Seed funding to revolutionize cancer treatment with cutting-edge technology and promising vaccine candidates. Read more
Investments By Sector
Kindred Capital has invested in these sectors
| Biotech | 40.0% |
| Proptech | 20.0% |
| Healthtech | 20.0% |
| AI | 10.0% |
